Validation experiment designed to validate causal mechanisms targeting N/A in mice. Primary outcome: anxiety- and depression-like behaviors
This bacteriotherapy experiment involved fecal microbiota transplantation (FMT) from lycopene-treated mice to investigate whether the beneficial effects of lycopene against DEHP-induced neurotoxicity could be transferred through gut microbiota. The study aimed to demonstrate that the neuroprotective effects of lycopene are mediated through its modulation of gut microbiota composition. Mice that received FMT from lycopene-treated donors were evaluated for behavioral improvements, specifically anxiety- and depression-like behaviors that are typically induced by DEHP exposure. This experiment served as a critical validation that the gut microbiota plays a central role in lycopene's neuroprotective mechanisms, supporting the gut-brain axis hypothesis. The successful amelioration of DEHP-induced behavioral deficits through FMT provided compelling evidence that beneficial gut bacteria can confer neuroprotection, establishing bacteriotherapy as a potential therapeutic strategy.
Fecal microbiota transplantation from lycopene-treated mice to recipient mice, followed by behavioral assessments
FMT from Lyc-treated mice would ameliorate DEHP-induced behavioral deficits
Improvement in anxiety- and depression-like behaviors comparable to direct Lyc treatment
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.